Genetic

Marfan Syndrome (Cardiac).

Expert second opinions for marfan syndrome (cardiac). Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.

1 in 5,000
Prevalence
Prophylactic surgery has normalized life expectancy
Key Outcome
Valve-sparing root replacement preferred at expert centers
Procedures
Quick Answer

Marfan Syndrome (Cardiac) ic connective tissue disorder affecting approximately 1 in 5,000 people. If you are facing a decision about marfan syndrome (cardiac), an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →

Overview

Understanding marfan syndrome (cardiac).

Marfan syndrome is a genetic connective tissue disorder affecting approximately 1 in 5,000 people. The most life-threatening manifestations involve the cardiovascular system — primarily aortic root dilation with risk of dissection, and mitral valve prolapse with regurgitation.

Why It Matters

Why you need a second opinion.

Cardiac management of Marfan syndrome requires lifelong surveillance and expert surgical timing. The threshold for prophylactic aortic root surgery is lower (4.5-5.0 cm) than for degenerative aneurysms. Valve-sparing root replacement is strongly preferred when feasible. Expertise in both connective tissue disorders and complex aortic surgery is essential.

Critical Decisions

Key decisions for marfan syndrome (cardiac).

Aortic root surgery timing and technique
Valve-sparing root replacement candidacy
Beta-blocker vs losartan for aortic growth prevention
Mitral valve management strategy
Pregnancy planning and cardiovascular risk
Risk Factors

What affects your risk.

Aortic root size and growth rate
Family history of aortic events
FBN1 mutation type
Mitral valve prolapse severity
Aortic regurgitation development
Our Review

What our Heart Team provides.

Dual-physician review (cardiac surgeon + cardiologist)
Triple risk scoring (STS PROM, EuroSCORE II, AATS)
ACC/AHA guideline mapping with evidence grades
Treatment alternatives with risk-benefit comparison
Surgeon and institution matching via Sentinel
Personalized question guide for your next appointment
Complete provenance trail for every conclusion
Results delivered within 24 hours
Common Questions

Frequently asked questions.

Do I need surgery for marfan syndrome (cardiac)?

Surgery for marfan syndrome (cardiac) depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. Cardiac management of Marfan syndrome requires lifelong surveillance and expert surgical timing. The threshold for prophylactic aortic root surgery is lower (4.5-5.0 cm) than for degenerative aneurysms. Valve-sparing root replacement is strongly preferred when feasible. Expertise in both connective tissue disorders and complex aortic surgery is essential.

What are the risks of marfan syndrome (cardiac) surgery?

Operative mortality for marfan syndrome (cardiac)-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.

Should I get a second opinion before marfan syndrome (cardiac) surgery?

Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.

What is the best treatment for marfan syndrome (cardiac)?

The optimal treatment for marfan syndrome (cardiac) depends on anatomy, comorbidities, age, and personal goals. Aortic root surgery timing and technique. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.

Clinical References
  1. Isselbacher EM, Preventza O, Hamilton Black J, et al. 2022 ACC/AHA Aortic Disease Guideline — Genetic Aortopathy Section. Circulation. 2022;146(24):e334-e482.
  2. Pyeritz RE. The Marfan syndrome. Annu Rev Med. 2000;51:481-510.
  3. O'Brien SM, Feng L, He X, et al. The Society of Thoracic Surgeons 2018 Adult Cardiac Surgery Risk Models. Ann Thorac Surg. 2018;105(5):1411-1418.
  4. Nashef SAM, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734-745.

Reading on marfan syndrome (cardiac)

See all articles →
Treatment Options
Aortic Root Replacement and the Bentall Procedure: What Patients Need to Know Before Surgery

Aortic root replacement is one of the most consequential operations in cardiac surgery. This guide explains the Bentall procedure, valve-sparing root replacement, and how to decide which approach is right for you.

Callistus Ditah, MD · May 23, 2026
Risk Assessment
EuroSCORE II Explained: What This European Cardiac Surgery Risk Score Means for Your Heart Surgery Decision

EuroSCORE II is one of the most widely used risk calculators in cardiac surgery worldwide. Learn what the European cardiac surgery risk score actually measures, how it compares to the STS risk model, and why understanding your score matters before you consent to an operation.

Serrie Lico, MD · May 24, 2026
Diagnostics
Cardiac Stress Test Results: What Your Exercise Echo or Nuclear Stress Test Actually Means

A world-class imaging cardiologist explains how to read and understand your cardiac stress test results — whether you had an exercise stress echo, nuclear stress test, or pharmacologic study. Learn what abnormal findings really mean for your heart and what comes next.

Kunal U. Gurav, MD · May 23, 2026
Risk Assessment
EuroSCORE II Explained: What This European Cardiac Surgery Risk Score Means for Your Heart Surgery Decision

EuroSCORE II is one of the most widely used cardiac surgery risk calculators in the world. As a cardiovascular surgeon, I explain what this European risk score measures, how it compares to the STS risk model, and what patients need to understand before surgery.

Rahul R. Handa, MD · May 22, 2026

Related conditions.

Loeys-Dietz Syndrome (Cardiac)

Get an expert opinion on your marfan syndrome (cardiac).

WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.

Start Your Review Try the Risk Calculator